Shopping Cart Found For example@example.com
We found a shopping cart for example@example.com, but you already have items in your cart.
The found cart for example@example.com contains:
Your current cart :
SEDA 7-Hydroxymitragynine Chewable Tablets 1ct 30mg Per Tablet
SEDA 7-Hydroxymitragynine Chewable Tablets 1ct 30mg Per Tablet
Regular price
$4.75 USD
Regular price
Sale price
$4.75 USD
Unit price
per
Shipping calculated at checkout.
Couldn't load pickup availability
%3Cp%3EEarn%20[points_amount]%20when%20you%20buy%20this%20item.%3C/p%3E
Secured checkout with
Quality & Value
Best Competitive Pricing Anywhere
Fast Fulfillment
We Pack In Hours Mon thru Sat
Safe Payment
Secure Checkout with Visa/MC
DESCRIPTION
7-Hydroxy 30mg Chewable Tablets by SEDA
Try SEDA 7-Hydroxymitragynine Chewable Tablets in a convenient single-tablet format, featuring 30mg of pure 7-hydroxymitragynine per tablet. Perfect for sampling or occasional use, this 1-count package is available in three mouthwatering flavors: Cherry Blast, Blue Raspberry, and Strawberry Watermelon.
Premium 30mg 7-Hydroxymitragynine Single Tablet
SEDA's single-serve chewable tablet delivers a moderate 30mg dose of 7-hydroxymitragynine, the most potent alkaloid derived from kratom (Mitragyna speciosa). This convenient 1-count format is ideal for first-time SEDA users, travelers, or those who prefer to purchase individual servings.
Available Flavors - Choose Your Favorite
π Cherry Blast: Bold, sweet cherry flavor with tangy notes
π Blue Raspberry: Classic blue razz taste sensation
π Strawberry Watermelon: Refreshing summer fruit fusion
Why Choose the 1-Count Single Tablet?
The SEDA 1ct single tablet format offers unique advantages for various user needs:
- Perfect for First-Timers: Try SEDA chewables without committing to multi-packs
- Flavor Testing: Sample different flavors before buying larger quantities
- Travel-Friendly: Ultra-portable single-serve packaging
- Occasional Use: Ideal for infrequent users who don't need bulk packages
- Budget-Friendly: Lower upfront cost for trial purposes
- Gift Sampling: Share with friends to introduce them to SEDA quality
- Dosage Testing: Assess your tolerance with a single 30mg serving
Understanding the 30mg Dosage
At 30mg of 7-hydroxymitragynine, this tablet provides a moderate-strength dose suitable for users with some kratom experience. This dosage sits between entry-level and high-potency options, making it versatile for various tolerance levels.
WARNING: This product contains 7-Hydroxymitragynine (7-OH) and should always be used responsibly and only as directed. Keep Out of Reach of Children. This product is not intended to diagnose, treat, cure, or prevent any medical condition or disease and may be harmful to your health. FDA has not approved 7OH for therapeutic uses. Consult a health provider for questions regarding 7OH use. Do not use this product: (1) if the product is damaged or has been opened prior to use; (2) in combination with any psychoactive, intoxicating or impairing substance including other botanical products , alcohol, nicotine, cannabinoids, or illicit substances; (3) if you have health conditions (including but not limited to any heart or liver disease or disorder, or high blood pressure) or use prescription medicine, over-the-counter drugs or dietary supplements except under physician supervision; (4) if you are pregnant, may become pregnant, or are breastfeeding; or (5) before engaging in dangerous activities, operating machinery or operating a motor vehicle. This product is not intended to be used or sold as an alternative to alcohol, nicotine, cannabinoids, prescription medications, or any other substance.β― This product is not intended to be used or sold for the treatment of any disease, illness or injury for which physician care should be sought.β― 7OH may be habit forming.β―If youβ―struggle with addiction or dependency or have questions regarding 7OH, consult a physician before using this product. If you experience any adverse effects from using this product, seekβ―immediate medical attention.
These statements have not been evaluated by the United States Food and Drug Administration.